Nalidixic acid USP27
Nalidixic acid USP27 Brand names, Nalidixic acid USP27 Analogs
Nalidixic acid USP27 Brand Names Mixture
- No information avaliable
Nalidixic acid USP27 Chemical_Formula
C10H15N3
Nalidixic acid USP27 RX_link
No information avaliable
Nalidixic acid USP27 fda sheet
Nalidixic acid USP27 msds (material safety sheet)
Nalidixic acid USP27 Synthesis Reference
No information avaliable
Nalidixic acid USP27 Molecular Weight
177.25 g/mol
Nalidixic acid USP27 Melting Point
196 oC
Nalidixic acid USP27 H2O Solubility
207 mg/L
Nalidixic acid USP27 State
Solid
Nalidixic acid USP27 LogP
1.493
Nalidixic acid USP27 Dosage Forms
Tablet for oral administration
Nalidixic acid USP27 Indication
For the treatment of hypertension.
Nalidixic acid USP27 Pharmacology
Betanidine is a guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear. Although bethanidine may produce adverse effects, they are beneficial in severe hypertension and produce fewer side effects than guanethidine.
Nalidixic acid USP27 Absorption
Absorbed rapidly in the gastrointestinal tract following oral administration.
Nalidixic acid USP27 side effects and Toxicity
No information avaliable
Nalidixic acid USP27 Patient Information
No information avaliable
Nalidixic acid USP27 Organisms Affected
Humans and other mammals
